Lan Zhong

1.4k total citations
50 papers, 983 citations indexed

About

Lan Zhong is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Lan Zhong has authored 50 papers receiving a total of 983 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Epidemiology and 8 papers in Oncology. Recurrent topics in Lan Zhong's work include Liver Disease Diagnosis and Treatment (10 papers), Cancer-related gene regulation (6 papers) and Liver Disease and Transplantation (5 papers). Lan Zhong is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Cancer-related gene regulation (6 papers) and Liver Disease and Transplantation (5 papers). Lan Zhong collaborates with scholars based in China, Hong Kong and United Kingdom. Lan Zhong's co-authors include Yanhao Xu, Qian Tao, Lili Li, Bo Wang, Xiaoming Wu, Xiaoping Fang, Jianbo Wang, Tingxiu Xiang, Jianming Ying and Anthony T.�C. Chan and has published in prestigious journals such as PLoS ONE, Oncogene and Journal of Materials Chemistry A.

In The Last Decade

Lan Zhong

46 papers receiving 972 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lan Zhong China 18 521 250 150 121 102 50 983
Jianguo Zhou China 16 443 0.9× 121 0.5× 79 0.5× 201 1.7× 94 0.9× 45 764
Yan‐Jiun Huang Taiwan 17 354 0.7× 187 0.7× 135 0.9× 226 1.9× 131 1.3× 48 901
Guangming Li China 20 777 1.5× 435 1.7× 359 2.4× 87 0.7× 63 0.6× 55 1.3k
Jiangping He China 13 655 1.3× 143 0.6× 103 0.7× 65 0.5× 52 0.5× 30 949
Bart Westendorp Netherlands 16 604 1.2× 55 0.2× 167 1.1× 270 2.2× 79 0.8× 41 869
Séverine Celton‐Morizur France 17 775 1.5× 141 0.6× 196 1.3× 148 1.2× 261 2.6× 26 1.3k
Tze-Tze Liu Taiwan 17 459 0.9× 118 0.5× 83 0.6× 32 0.3× 68 0.7× 38 887
Bin Xue China 14 395 0.8× 78 0.3× 83 0.6× 107 0.9× 45 0.4× 25 619
Zhiyong Deng China 14 410 0.8× 139 0.6× 136 0.9× 67 0.6× 45 0.4× 27 699

Countries citing papers authored by Lan Zhong

Since Specialization
Citations

This map shows the geographic impact of Lan Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Zhong more than expected).

Fields of papers citing papers by Lan Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Zhong. The network helps show where Lan Zhong may publish in the future.

Co-authorship network of co-authors of Lan Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Zhong. A scholar is included among the top collaborators of Lan Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Zhong. Lan Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Dongmei, et al.. (2025). Advances in PD-1 and CTLA-4 dual-target immunotherapy for ovarian cancer. Frontiers in Immunology. 16. 1686532–1686532.
2.
Hu, Jiali, et al.. (2024). Human umbilical cord mesenchymal stem cells attenuate diet-induced obesity and NASH-related fibrosis in mice. Heliyon. 10(3). e25460–e25460. 9 indexed citations
3.
Zhang, Shuo, et al.. (2023). Predicting the risk of variceal rehemorrhage in cirrhotic patients with portal vein thrombosis: A two‐center retrospective study. Journal of Digestive Diseases. 24(11). 619–629. 1 indexed citations
5.
Zhuang, Wei, Jinfeng Zhou, Lan Zhong, et al.. (2023). CXCR1 drives the pathogenesis of EAE and ARDS via boosting dendritic cells-dependent inflammation. Cell Death and Disease. 14(9). 608–608. 13 indexed citations
6.
Ye, Lu, Danqing Wang, Qingli Li, et al.. (2023). Chemotherapy effect on myocardial fibrosis markers in patients with gynecologic cancer and low cardiovascular risk. Frontiers in Oncology. 13. 1173838–1173838. 2 indexed citations
8.
Zhang, Dan, et al.. (2022). Dissipation, uptake, translocation and accumulation of five phthalic acid esters in sediment-Zizania latifolia system. Chemosphere. 315. 137651–137651. 7 indexed citations
9.
Zhang, Shuo, et al.. (2022). A Dynamic Nomogram Predicting Portal Vein Thrombosis in Cirrhotic Patients During Primary Prophylaxis for Variceal Hemorrhage. Frontiers in Medicine. 9. 887995–887995. 3 indexed citations
10.
Sun, Qin-Juan, Jie Jian, Chenkai Huang, et al.. (2021). The Role of Bone Morphogenetic Protein 9 in Nonalcoholic Fatty Liver Disease in Mice. Frontiers in Pharmacology. 11. 605967–605967. 19 indexed citations
11.
Hu, Miao, Ying Tong, Jie Tang, et al.. (2020). IL36 indicating good prognosis in human Hepatocellular Carcinoma. Journal of Cancer. 11(21). 6248–6255. 10 indexed citations
12.
Wang, Yan, Qianqian Li, Lili Li, et al.. (2019). ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer. Clinical Epigenetics. 11(1). 184–184. 25 indexed citations
13.
Chen, Songwen, et al.. (2016). Potential role of cyanidin 3-glucoside (C3G) in diabetic cardiomyopathy in diabetic rats: An in vivo approach. Saudi Journal of Biological Sciences. 25(3). 500–506. 30 indexed citations
14.
Li, Lili, Mingfang Ji, Yingduan Cheng, et al.. (2013). FEZF2 , a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma. Carcinogenesis. 34(9). 1984–1993. 38 indexed citations
15.
Li, Lili, Jianming Ying, Xin Tong, et al.. (2013). Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas. Cellular and Molecular Life Sciences. 71(11). 2179–2192. 39 indexed citations
16.
Han, Junyi, Yang Yao, Hua Yin, et al.. (2012). Lentivirus-mediated knockdown of rhomboid domain containing 1 inhibits colorectal cancer cell growth. Molecular Medicine Reports. 12(1). 377–381. 10 indexed citations
17.
Su, Pen‐Hua, Hao Ding, Yaoqi Zhou, et al.. (2011). A 4.6 kb genomic duplication on 20p12.2–12.3 is associated with brachydactyly type A2 in a Chinese family. Journal of Medical Genetics. 48(5). 312–316. 9 indexed citations
18.
Liu, Fei, et al.. (2010). Model for end‐stage liver disease combined with serum prealbumin to predict the prognosis of patients with decompensated liver cirrhosis. Journal of Digestive Diseases. 11(6). 352–357. 20 indexed citations
19.
Xu, Yanhao, Lan Zhong, Xiaoming Wu, Xiaoping Fang, & Jianbo Wang. (2008). Rapid alterations of gene expression and cytosine methylation in newly synthesized Brassica napus allopolyploids. Planta. 229(3). 471–483. 120 indexed citations
20.
Zhong, Lan. (2002). Putative cytochrome P450 genes in rice genome (Oryza sativa L. ssp. indica) and their EST evidence. Science in China Series C Life Sciences. 45(5). 512–512. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026